EASL 2026 Interview: Ana Lleo
Hepatologist Ana Lleo discusses her career path and the evolution of liver disease research, highlighting the shift from viral hepatitis to metabolic dysfunction-associated steatotic liver disease (MASLD). She emphasizes the critical role of international collaboration in addressing rare liver conditions.
Why it matters
Understanding the shifting focus of hepatology research is essential for medical professionals and patients navigating the changing landscape of chronic liver disease treatments.
Ana Lleo | P rofessor of Internal Medicine , Humanitas University ; Consultant Hepatologist and H ead of the Center for Autoimmune Liver Diseases , Division of Internal Medicine and Hepatology, IRCCS Humanitas Research Hospital; Head of the Hepatobiliary Immunopathology Laboratory, Humanitas Research Hospital, Milan, Italy
Citation: EMJ Hepatol . 2026; 14[1 ]: https://doi.org/10.33590/emjhepatol/RE9QA6H6
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in